UNSPSC 51473304: Biclotymol

This classification denotes an anti-infective agent with the molecular formula C21H26Cl2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier W4K0AE8XW9, chemically known as 6,6-dichlor-2,2-methylendithymol but generally known as biclotymol, which bears US NIH Compound Identifier 71878. European Medicines Agency schedules Biclotymol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05821MIG.

UNSPSC 51473304 Biclotymol, a Commodity code, covers antimicrobial agents and related chemical products that state and local governments procure as consumable supplies for facility operations, hygiene, and pharmaceutical applications. Recent solicitations show that state and local buyers source this material primarily through two channels: janitorial and operational supply contracts for fire rescue and public-safety facilities, and multi-source pharmaceutical and over-the-counter product agreements that bundle generic pharmaceuticals and chemical agents for distribution across state and local healthcare, institutional, and operational networks. The issuing bodies include county commissioners' offices, state procurement departments, and multi-state cooperative purchasing alliances; Hillsborough County (Florida) and the Minnesota Department of Administration appear as recent active buyers.

Activity under the code spans Florida and Minnesota with broader reach through cooperative purchasing vehicles. The Hillsborough County Board of County Commissioners issued an ITB for janitorial and operational supplies due July 24, 2026, with an estimated contract value of $765,679.84 to serve 47 fire stations; delivery is required within 10 days of purchase order receipt to the Public Safety Operations Complex in Tampa. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, issued an RFP due March 26, 2026, to establish multiple contracts for generic multi-source pharmaceuticals and OTC products distributed across participating state and local government facilities, including Oregon; awarded vendors must be available by May 1, 2026, with contracts effective July 1, 2026, and must maintain relationships with AmerisourceBergen Drug Corporation (Cencora), Cardinal Health, and Morris & Dickson Co., LLC as authorized wholesalers.